Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month study.

Journal: Medical hypothesis, discovery & innovation ophthalmology journal
Published Date: Dec 31, 2023

Abstract

BACKGROUND: Diabetic macular edema (DME) affects approximately 10% of patients with diabetes mellitus. This condition can cause blurred or distorted vision, which significantly affects the quality of life of these patients. We evaluated the therapeutic effects of intravitreal methotrexate (MTX) injections on persistent DME.

Authors

  • Nayyereh Razzaghpour
    Department of Ophthalmology, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Amin Najafi
    Department of Ophthalmology, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Mohammad Rasoul Sabouri
    Department of Ophthalmology, Guilan University of Medical Sciences, Rasht, Iran.
  • Negin Ashoori
    Department of Ophthalmology, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Kourosh Shahraki
    Department of Ophthalmology, Zahedan University of Medical Sciences, Zahedan, Iran.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals